Patent · US Active

2-phenylimidazo[4,5-b]pyridin-7-amine derivates useful as inhibitors of mammalian tyrosine kinase ROR1 activity

US11008318B2 · kind B2 · utility

0Cited by

1References

20Claims

0Family size

Assignee

Kancera AB · SE

Inventors

Hakan Mellstedt · Stockholm, SE
Styrbjörn Byström · Solna, SE
Jan Vågberg · Sollentuna, SE
Elisabeth Olsson · Sollentuna, SE

Key dates

Filing date	Jul 10, 2017
Grant date	May 18, 2021
Priority date	—
Expiry date	Jul 10, 2037

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P43/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Compound of formula (I′) or (I″) or a pharmaceutically acceptable salt thereof. The compound is an inhibitor of mammalian kinase enzyme activity, including ROR1 tyrosine kinase activity and may be used in the treatment of disorders associated with such activity.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.